产品中心 抗体 其他一抗

所有图片(1/2)

PI3 Kinase p110α Recombinant Rabbit mAb (S-3130)

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform,PI3-kinase subunit alpha,PI3K-alpha,PI3Kalpha,PtdIns-3-kinase subunit alpha,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha (PtdIns-3-kinase subunit p110-alpha,p110alpha),Phosphoinositide 3-kinase alpha,Phosphoinositide-3-kinase catalytic alpha polypeptide,Serine/threonine protein kinase PIK3CA,PIK3CA

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6187
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    PI3 Kinase p110α
  • 分子别名

    Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3-kinase subunit alpha; PI3K-alpha; PI3Kalpha; PtdIns-3-kinase subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha (PtdIns-3-kinase subunit p110-alpha; p110alpha); Phosphoinositide 3-kinase alpha; Phosphoinositide-3-kinase catalytic alpha polypeptide; Serine/threonine protein kinase PIK3CA; PIK3CA
  • 细胞定位

    Cytoplasm
  • Accession

    P42336
  • 克隆号

    S-3130
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Ms, Rt
  • 阳性样本

    NIH/3T3, C2C12, mouse brain
  • 预测反应种属
    (反应种属缩写表)

    Bv
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu, Ms
背景介绍
  • PI3 Kinase p110α (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) is a 1,068-amino-acid lipid kinase that, in complex with its regulatory subunit p85, phosphorylates PIP₂ to generate the second messenger PIP₃, thereby activating the PI3K/AKT/mTOR pathway that controls cell growth, survival, metabolism, and angiogenesis; encoded by PIK3CA, it contains an N-terminal adaptor-binding domain, a Ras-binding domain, a C2 domain, a helical domain, and a C-terminal kinase domain, and is the most frequently mutated oncogene in human cancers, with hotspot mutations (e.g., E545K and H1047R) causing constitutive lipid kinase activity and driving tumorigenesis.

  • 免疫印迹

    • WB result of PI3 Kinase p110α Recombinant Rabbit mAb
      Primary antibody: PI3 Kinase p110α Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: HeLa whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 124 kDa
      Observed MW: 110 kDa

    • WB result of PI3 Kinase p110α Recombinant Rabbit mAb
      Primary antibody: PI3 Kinase p110α Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: NIH/3T3 whole cell lysate 20 µg
      Lane 2: C2C12 whole cell lysate 20 µg
      Lane 3: mouse brain lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 124 kDa
      Observed MW: 110 kDa

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)